Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 896 (108th)

Breast Cancer Prescription Drug Fairness Act of 2003

referredUnited States· United States Congress· EN

Introduced

25 February 2003

Last action

10 March 2003 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. McCarthy, Carolyn [D-NY-4], Rep. Kilpatrick, Carolyn C. [D-MI-13], Rep. Payne, Donald M. [D-NJ-10], Rep. McNulty, Michael R. [D-NY-23], Rep. Ackerman, Gary L. [D-NY-5], Rep. Israel, Steve [D-NY-3], Rep. Frank, Barney [D-MA-4], Rep. Frost, Martin [D-TX-24], Rep. Owens, Major R. [D-NY-11], Rep. Kildee, Dale E. [D-MI-5], Rep. Doggett, Lloyd [D-TX-37], Rep. Woolsey, Lynn C. [D-CA-6], Rep. Johnson, Eddie Bernice [D-TX-30], Del. Bordallo, Madeleine Z. [D-GU-At Large], Rep. Davis, Danny K. [D-IL-7], Rep. Abercrombie, Neil [D-HI-1], ROBERT BRADY, Rep. Carson, Julia [D-IN-7], Rep. Lee, Barbara [D-CA-12], Rep. McIntyre, Mike [D-NC-7], Rep. Hinojosa, Ruben [D-TX-15]

Subjects

Healthcare

Source updated

18 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Breast Cancer Prescription Drug Fairness Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy a covered outpatient drug: (1) in an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries (including the amount sold or distributed to Medicare beneficiaries in a hospice program); and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 25 February 2003

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 25 February 2003

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  3. 25 February 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 25 February 2003

    Introduced

    Introduced in House

    Source: IntroReferral

  5. 10 March 2003

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 25 February 2003

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 25 February 2003

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 25 February 2003

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.